Canadian biotechnology developer QLT slashes workforce by two-thirds

VANCOUVER – Canadian biotechnology company QLT Inc. is cutting its workforce by two-thirds, leaving it with 68 employees after the downsizing.

The Vancouver-based company (TSX:QLT) had been one of Canada’s most successful biotechnology firms based on its treatment for age-related blindness.

But sales of Visudyne have fallen and QLT has struggled in recent years to find another commercially successful product.

As a result, QLT’s chairman says the company is cutting 146 of its 214 remaining jobs.

He says the downsizing will reduce QLT’s annual operating expenses by $45 million to $50 million in 2013.

QLT’s new board of directors has also authorized a payout of $100 million to its shareholders in a process known as a return of capital.

News from © iNFOnews.ca, . All rights reserved.
This material may not be published, broadcast, rewritten or redistributed.